These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


326 related items for PubMed ID: 9525584

  • 21. Human endogenous retroviral long terminal repeat sequences as cell type-specific promoters in retroviral vectors.
    Schön U, Diem O, Leitner L, Günzburg WH, Mager DL, Salmons B, Leib-Mösch C.
    J Virol; 2009 Dec; 83(23):12643-50. PubMed ID: 19741000
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. HERV-K: the biologically most active human endogenous retrovirus family.
    Tönjes RR, Löwer R, Boller K, Denner J, Hasenmaier B, Kirsch H, König H, Korbmacher C, Limbach C, Lugert R, Phelps RC, Scherer J, Thelen K, Löwer J, Kurth R.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Dec; 13 Suppl 1():S261-7. PubMed ID: 8797733
    [Abstract] [Full Text] [Related]

  • 24. Defective herpes simplex virus type 1 vectors harboring gag, pol, and env genes can be used to rescue defective retrovirus vectors.
    Savard N, Cosset FL, Epstein AL.
    J Virol; 1997 May; 71(5):4111-7. PubMed ID: 9094692
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. A retroviral packaging cell line for pseudotype vectors based on glioma-infiltrating progenitor cells.
    Fischer YH, Miletic H, Giroglou T, Litwak S, Stenzel W, Neumann H, von Laer D.
    J Gene Med; 2007 May; 9(5):335-44. PubMed ID: 17474071
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Targeted gene transfer to lymphocytes using murine leukaemia virus vectors pseudotyped with spleen necrosis virus envelope proteins.
    Engelstädter M, Buchholz CJ, Bobkova M, Steidl S, Merget-Millitzer H, Willemsen RA, Stitz J, Cichutek K.
    Gene Ther; 2001 Aug; 8(15):1202-6. PubMed ID: 11509952
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Genome-wide screening, cloning, chromosomal assignment, and expression of full-length human endogenous retrovirus type K.
    Tönjes RR, Czauderna F, Kurth R.
    J Virol; 1999 Nov; 73(11):9187-95. PubMed ID: 10516026
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. High efficiency retroviral vectors that contain no viral coding sequences.
    Yu SS, Kim JM, Kim S.
    Gene Ther; 2000 May; 7(9):797-804. PubMed ID: 10822307
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Identification of an internal ribosome entry segment in the 5' region of the mouse VL30 retrotransposon and its use in the development of retroviral vectors.
    López-Lastra M, Ulrici S, Gabus C, Darlix JL.
    J Virol; 1999 Oct; 73(10):8393-402. PubMed ID: 10482590
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 17.